Placebo
ALN-APP-002
Phase 2 small_molecule active
Quick answer
Placebo for Cerebral Amyloid Angiopathy is a Phase 2 program (small_molecule) at ALNYLAM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Indication
- Cerebral Amyloid Angiopathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active